GAS5 and gastric cancer: GAS5 has been reported to be aberrantly expressed in some cancers, including lung cancer (Wu et al., 2016), cervical cancer (Cao et al., 2014), breast cancer (Pickard and Williams, 2016) and gastric cancer, and plays important roles in cell processes such as proliferation, invasion, migration and apoptosis.